Cargando…
Efficacy of Corticosteroids in Patients with SARS, MERS and COVID-19: A Systematic Review and Meta-Analysis
(1) Background: The use of corticosteroids in critical coronavirus infections, including severe acute respiratory syndrome (SARS), Middle East Respiratory Syndrome (MERS), or Coronavirus disease 2019 (COVID-19), has been controversial. However, a meta-analysis on the efficacy of steroids in treating...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465945/ https://www.ncbi.nlm.nih.gov/pubmed/32726951 http://dx.doi.org/10.3390/jcm9082392 |
_version_ | 1783577698643214336 |
---|---|
author | Lee, Keum Hwa Yoon, Sojung Jeong, Gwang Hun Kim, Jong Yeob Han, Young Joo Hong, Sung Hwi Ryu, Seohyun Kim, Jae Seok Lee, Jun Young Yang, Jae Won Lee, Jinhee Solmi, Marco Koyanagi, Ai Dragioti, Elena Jacob, Louis Radua, Joaquim Smith, Lee Oh, Hans Tizaoui, Kalthoum Cargnin, Sarah Terrazzino, Salvatore Ghayda, Ramy Abou Kronbichler, Andreas Shin, Jae Il |
author_facet | Lee, Keum Hwa Yoon, Sojung Jeong, Gwang Hun Kim, Jong Yeob Han, Young Joo Hong, Sung Hwi Ryu, Seohyun Kim, Jae Seok Lee, Jun Young Yang, Jae Won Lee, Jinhee Solmi, Marco Koyanagi, Ai Dragioti, Elena Jacob, Louis Radua, Joaquim Smith, Lee Oh, Hans Tizaoui, Kalthoum Cargnin, Sarah Terrazzino, Salvatore Ghayda, Ramy Abou Kronbichler, Andreas Shin, Jae Il |
author_sort | Lee, Keum Hwa |
collection | PubMed |
description | (1) Background: The use of corticosteroids in critical coronavirus infections, including severe acute respiratory syndrome (SARS), Middle East Respiratory Syndrome (MERS), or Coronavirus disease 2019 (COVID-19), has been controversial. However, a meta-analysis on the efficacy of steroids in treating these coronavirus infections is lacking. (2) Purpose: We assessed a methodological criticism on the quality of previous published meta-analyses and the risk of misleading conclusions with important therapeutic consequences. We also examined the evidence of the efficacy of corticosteroids in reducing mortality in SARS, MERS and COVID-19. (3) Methods: PubMed, MEDLINE, Embase, and Web of Science were used to identify studies published until 25 April 2020, that reported associations between steroid use and mortality in treating SARS/MERS/COVID-19. Two investigators screened and extracted data independently. Searches were restricted to studies on humans, and articles that did not report the exact number of patients in each group or data on mortality were excluded. We calculated odds ratios (ORs) or hazard ratios (HRs) under the fixed- and random-effect model. (4) Results: Eight articles (4051 patients) were eligible for inclusion. Among these selected studies, 3416 patients were diagnosed with SARS, 360 patients with MERS, and 275 with COVID-19; 60.3% patients were administered steroids. The meta-analyses including all studies showed no differences overall in terms of mortality (OR 1.152, 95% CI 0.631–2.101 in the random effects model, p = 0.645). However, this conclusion might be biased, because, in some studies, the patients in the steroid group had more severe symptoms than those in the control group. In contrast, when the meta-analysis was performed restricting only to studies that used appropriate adjustment (e.g., time, disease severity), there was a significant difference between the two groups (HR 0.378, 95% CI 0.221–0.646 in the random effects model, p < 0.0001). Although there was no difference in mortality when steroids were used in severe cases, there was a difference among the group with more underlying diseases (OR 3.133, 95% CI 1.670–5.877, p < 0.001). (5) Conclusions: To our knowledge, this study is the first comprehensive systematic review and meta-analysis providing the most accurate evidence on the effect of steroids in coronavirus infections. If not contraindicated, and in the absence of side effects, the use of steroids should be considered in coronavirus infection including COVID-19. |
format | Online Article Text |
id | pubmed-7465945 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-74659452020-09-04 Efficacy of Corticosteroids in Patients with SARS, MERS and COVID-19: A Systematic Review and Meta-Analysis Lee, Keum Hwa Yoon, Sojung Jeong, Gwang Hun Kim, Jong Yeob Han, Young Joo Hong, Sung Hwi Ryu, Seohyun Kim, Jae Seok Lee, Jun Young Yang, Jae Won Lee, Jinhee Solmi, Marco Koyanagi, Ai Dragioti, Elena Jacob, Louis Radua, Joaquim Smith, Lee Oh, Hans Tizaoui, Kalthoum Cargnin, Sarah Terrazzino, Salvatore Ghayda, Ramy Abou Kronbichler, Andreas Shin, Jae Il J Clin Med Article (1) Background: The use of corticosteroids in critical coronavirus infections, including severe acute respiratory syndrome (SARS), Middle East Respiratory Syndrome (MERS), or Coronavirus disease 2019 (COVID-19), has been controversial. However, a meta-analysis on the efficacy of steroids in treating these coronavirus infections is lacking. (2) Purpose: We assessed a methodological criticism on the quality of previous published meta-analyses and the risk of misleading conclusions with important therapeutic consequences. We also examined the evidence of the efficacy of corticosteroids in reducing mortality in SARS, MERS and COVID-19. (3) Methods: PubMed, MEDLINE, Embase, and Web of Science were used to identify studies published until 25 April 2020, that reported associations between steroid use and mortality in treating SARS/MERS/COVID-19. Two investigators screened and extracted data independently. Searches were restricted to studies on humans, and articles that did not report the exact number of patients in each group or data on mortality were excluded. We calculated odds ratios (ORs) or hazard ratios (HRs) under the fixed- and random-effect model. (4) Results: Eight articles (4051 patients) were eligible for inclusion. Among these selected studies, 3416 patients were diagnosed with SARS, 360 patients with MERS, and 275 with COVID-19; 60.3% patients were administered steroids. The meta-analyses including all studies showed no differences overall in terms of mortality (OR 1.152, 95% CI 0.631–2.101 in the random effects model, p = 0.645). However, this conclusion might be biased, because, in some studies, the patients in the steroid group had more severe symptoms than those in the control group. In contrast, when the meta-analysis was performed restricting only to studies that used appropriate adjustment (e.g., time, disease severity), there was a significant difference between the two groups (HR 0.378, 95% CI 0.221–0.646 in the random effects model, p < 0.0001). Although there was no difference in mortality when steroids were used in severe cases, there was a difference among the group with more underlying diseases (OR 3.133, 95% CI 1.670–5.877, p < 0.001). (5) Conclusions: To our knowledge, this study is the first comprehensive systematic review and meta-analysis providing the most accurate evidence on the effect of steroids in coronavirus infections. If not contraindicated, and in the absence of side effects, the use of steroids should be considered in coronavirus infection including COVID-19. MDPI 2020-07-27 /pmc/articles/PMC7465945/ /pubmed/32726951 http://dx.doi.org/10.3390/jcm9082392 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Lee, Keum Hwa Yoon, Sojung Jeong, Gwang Hun Kim, Jong Yeob Han, Young Joo Hong, Sung Hwi Ryu, Seohyun Kim, Jae Seok Lee, Jun Young Yang, Jae Won Lee, Jinhee Solmi, Marco Koyanagi, Ai Dragioti, Elena Jacob, Louis Radua, Joaquim Smith, Lee Oh, Hans Tizaoui, Kalthoum Cargnin, Sarah Terrazzino, Salvatore Ghayda, Ramy Abou Kronbichler, Andreas Shin, Jae Il Efficacy of Corticosteroids in Patients with SARS, MERS and COVID-19: A Systematic Review and Meta-Analysis |
title | Efficacy of Corticosteroids in Patients with SARS, MERS and COVID-19: A Systematic Review and Meta-Analysis |
title_full | Efficacy of Corticosteroids in Patients with SARS, MERS and COVID-19: A Systematic Review and Meta-Analysis |
title_fullStr | Efficacy of Corticosteroids in Patients with SARS, MERS and COVID-19: A Systematic Review and Meta-Analysis |
title_full_unstemmed | Efficacy of Corticosteroids in Patients with SARS, MERS and COVID-19: A Systematic Review and Meta-Analysis |
title_short | Efficacy of Corticosteroids in Patients with SARS, MERS and COVID-19: A Systematic Review and Meta-Analysis |
title_sort | efficacy of corticosteroids in patients with sars, mers and covid-19: a systematic review and meta-analysis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465945/ https://www.ncbi.nlm.nih.gov/pubmed/32726951 http://dx.doi.org/10.3390/jcm9082392 |
work_keys_str_mv | AT leekeumhwa efficacyofcorticosteroidsinpatientswithsarsmersandcovid19asystematicreviewandmetaanalysis AT yoonsojung efficacyofcorticosteroidsinpatientswithsarsmersandcovid19asystematicreviewandmetaanalysis AT jeonggwanghun efficacyofcorticosteroidsinpatientswithsarsmersandcovid19asystematicreviewandmetaanalysis AT kimjongyeob efficacyofcorticosteroidsinpatientswithsarsmersandcovid19asystematicreviewandmetaanalysis AT hanyoungjoo efficacyofcorticosteroidsinpatientswithsarsmersandcovid19asystematicreviewandmetaanalysis AT hongsunghwi efficacyofcorticosteroidsinpatientswithsarsmersandcovid19asystematicreviewandmetaanalysis AT ryuseohyun efficacyofcorticosteroidsinpatientswithsarsmersandcovid19asystematicreviewandmetaanalysis AT kimjaeseok efficacyofcorticosteroidsinpatientswithsarsmersandcovid19asystematicreviewandmetaanalysis AT leejunyoung efficacyofcorticosteroidsinpatientswithsarsmersandcovid19asystematicreviewandmetaanalysis AT yangjaewon efficacyofcorticosteroidsinpatientswithsarsmersandcovid19asystematicreviewandmetaanalysis AT leejinhee efficacyofcorticosteroidsinpatientswithsarsmersandcovid19asystematicreviewandmetaanalysis AT solmimarco efficacyofcorticosteroidsinpatientswithsarsmersandcovid19asystematicreviewandmetaanalysis AT koyanagiai efficacyofcorticosteroidsinpatientswithsarsmersandcovid19asystematicreviewandmetaanalysis AT dragiotielena efficacyofcorticosteroidsinpatientswithsarsmersandcovid19asystematicreviewandmetaanalysis AT jacoblouis efficacyofcorticosteroidsinpatientswithsarsmersandcovid19asystematicreviewandmetaanalysis AT raduajoaquim efficacyofcorticosteroidsinpatientswithsarsmersandcovid19asystematicreviewandmetaanalysis AT smithlee efficacyofcorticosteroidsinpatientswithsarsmersandcovid19asystematicreviewandmetaanalysis AT ohhans efficacyofcorticosteroidsinpatientswithsarsmersandcovid19asystematicreviewandmetaanalysis AT tizaouikalthoum efficacyofcorticosteroidsinpatientswithsarsmersandcovid19asystematicreviewandmetaanalysis AT cargninsarah efficacyofcorticosteroidsinpatientswithsarsmersandcovid19asystematicreviewandmetaanalysis AT terrazzinosalvatore efficacyofcorticosteroidsinpatientswithsarsmersandcovid19asystematicreviewandmetaanalysis AT ghaydaramyabou efficacyofcorticosteroidsinpatientswithsarsmersandcovid19asystematicreviewandmetaanalysis AT kronbichlerandreas efficacyofcorticosteroidsinpatientswithsarsmersandcovid19asystematicreviewandmetaanalysis AT shinjaeil efficacyofcorticosteroidsinpatientswithsarsmersandcovid19asystematicreviewandmetaanalysis |